Piper Jaffray Merchant Banking
9
23M
9
4
1
- Areas of investment
Summary
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Medical Device. Among the various public portfolio startups of the fund, we may underline Clinicient, Sapphire Digital, Xenex The fund has no exact preference in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Piper Jaffray Merchant Banking, startups are often financed by Greycroft, Targeted Technology Fund, Shumway Capital. The meaningful sponsors for the fund in investment in the same round are Greycroft, Telegraph Hill Partners, Tectonic Ventures. In the next rounds fund is usually obtained by Goldman Sachs.
The important activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 4
- Exits
- 1
- Investments by industry
- Health Care (6)
- Hospital (2)
- Biotechnology (2)
- Wellness (2)
- Medical (2) Show 16 more
- Investments by region
-
- United States (9)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 0.89
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Integrity Orthopaedics | 30 Apr 2024 | Early Stage Venture | 20M | United States, Minnesota, Maple Plain |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.